Table 2.
Group | Baseline | 6 Months | 12 Months | 36 Months* |
---|---|---|---|---|
No treatment | ||||
| ||||
No. in group | 75 | 67 | 63 | 64 |
| ||||
M. perstans (microfilariae/ml) | ||||
| ||||
Median | 323 | 136 | 153 | 264 |
| ||||
Range | 17–20,128 | 0–5916 | 0–11,441 | 0–8305 |
| ||||
Doxycycline only | ||||
| ||||
No. in group | 76 | 67 | 69 | 64 |
| ||||
M. perstans (microfilariae/ml) | ||||
| ||||
Median | 357 | 51 | 0 | 0 |
| ||||
Range | 17–5712 | 0–1955 | 0–17 | 0–383 |
| ||||
Doxycycline with albendazole–ivermectin | ||||
| ||||
No. in group | 30 | 26 | 25 | 23 |
| ||||
M. perstans (microfilariae/ml) | ||||
| ||||
Median | 332 | 51 | 0 | 0 |
| ||||
Range | 17–8313 | 0–3315 | 0 | 0–102 |
| ||||
Albendazole–ivermectin only | ||||
| ||||
No. in group | 35 | 31 | 27 | 29 |
| ||||
M. perstans (microfilariae/ml) | ||||
| ||||
Median | 340 | 102 | 153 | 102 |
| ||||
Range | 17–6120 | 0–2108 | 0–799 | 0–3783 |
All subjects received a single dose of albendazole–ivermectin as part of the mass distribution program before the 36-month visit.